Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliane Mery

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
JCI Insight|December 17, 2020
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cellsCamille-Charlotte Balança, Anna Salvioni, Clara-Maria Scarlata, et al.
Genes, Chromosomes & Cancer|March 14, 2024
Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretationQuitterie Fontanges, Paul Dubos, Tom Lesluyes, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Cell Death and Differentiation|August 26, 2023
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitorBenjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, et al.
Nature|August 2, 2023
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancerPhilippe A Cassier, Raul Navaridas, Melanie Bellina, et al.
Cancer Immunology Research|April 17, 2020
Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial MalignanciesCamille-Charlotte Balança, Clara-Maria Scarlata, Marie Michelas, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
JCI Insight|December 17, 2020
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cellsCamille-Charlotte Balança, Anna Salvioni, Clara-Maria Scarlata, et al.
Genes, Chromosomes & Cancer|March 14, 2024
Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretationQuitterie Fontanges, Paul Dubos, Tom Lesluyes, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Cell Death and Differentiation|August 26, 2023
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitorBenjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, et al.
Nature|August 2, 2023
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancerPhilippe A Cassier, Raul Navaridas, Melanie Bellina, et al.
Cancer Immunology Research|April 17, 2020
Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial MalignanciesCamille-Charlotte Balança, Clara-Maria Scarlata, Marie Michelas, et al.
Pageof 6